{
    "Trade/Device Name(s)": [
        "Total Bile Acids Assay"
    ],
    "Submitter Information": "Diazyme Laboratories Division, General Atomics",
    "510(k) Number": "K051714",
    "Predicate Device Reference 510(k) Number(s)": [
        "K872296"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KWW",
        "JJX"
    ],
    "Summary Letter Date": "December 7, 2005",
    "Summary Letter Received Date": "November 18, 2005",
    "Submission Date": "November 18, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1177"
    ],
    "Regulation Name(s)": [
        "Cholylglycine test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Total bile acids"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Kinetic assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme Total Bile Acids Assay for in vitro quantitative determination of total bile acids in serum using enzymatic method",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of total bile acids (TBA) in human serum samples to aid in assessment of liver function",
    "fda_folder": "Clinical Chemistry"
}